LIGAND PHARMACEUTICALS INC — Director's Dealing 2017

Aug 22, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2017-08-18

Reporting Person: Gray Nancy Ryan (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-18	Common Stock	A	913	—	Acquired	913	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-18	Common Stock	$126.26	A	3452	Acquired	2027-08-18	Common Stock (3452.0)	Direct

Footnotes

F1: Non-Qualified Stock Option (right to buy)

F2: The option becomes exercisable in 3 successive equal annual installments upon completion of each calendar year of service beginning on the grant date.